Metropolis Healthcare Q2 Results 2025 Highlights: Net Profit Surged by 13.22% & Revenue Up 22.70% YoY

Click and Sign Up to Get Live Updates on Q2 Results 

Metropolis Healthcare Q2 Results FY26: During Q2 FY26, Metropolis Healthcare’s profit increased 13.22% YoY, while revenue increased by 22.70% YoY. The company posted robust numbers, with Q2 PAT at ₹52.67 crores and revenue at ₹429.19 crores. Metropolis Healthcare announced its Q2 results on 4th November 2025.  

Metropolis Healthcare Q2 Results FY26: Extracts of FY25 & FY26

Metropolis Healthcare Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

• Metropolis Healthcare clocked Q2 FY26 consolidated revenue of ₹429.19 crores vs ₹349.79 crores. 
• On the profit front, Metropolis Healthcare earned a consolidated PAT of ₹52.67 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹46.52 crore.
• According to the consolidated figures, Metropolis Healthcare’s quarterly PAT increased by 13.22% YoY, while revenue increased by 22.70%.
• Metropolis Healthcare clocked Q2 FY26 standalone revenue of ₹355.71 crores vs ₹321.57 crores. 
• On the profit front, Metropolis Healthcare earned a standalone PAT of ₹46.63 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹42.26 crore.
• According to the standalone figures, Metropolis Healthcare’s quarterly PAT increased by 10.34% YoY, while revenue increased by 10.62%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Metropolis Healthcare Share Price Performance

On the opening bell on 6th November 2025, Metropolis Healthcare shares opened at ₹2,106.50 per share. However, the initial gains have since eroded, and Metropolis Healthcare shares are currently trading at ₹1,981.50 per share, which is lower than the opening price.    

Considering the long-term achievements, Metropolis Healthcare shares have yielded returns of approximately -9.53% over the past years, and 5-year returns stand at 0.06%. Over the maximum timeframe, Metropolis Healthcare shares delivered a 104.22% return to investors. 

What Analysts Expect Post Q2 Results?

Following Metropolis Healthcare’s robust Q2 results, analysts expect its share price to rise. According to analysts, Metropolis Healthcare’s share price could reach ₹2,120.00 per share in the coming year; however, in a downturn, it could fall to ₹2,102.20 per share. However, one must ignore stock market volatility and invest in Metropolis Healthcare’s shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here